It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about its future evolution remain.

CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...

Specifically, we developed a statistical mechanics model that connects the thermodynamic properties of the virus's spike protein to its ability to spread. The key player in SARS-CoV-2's infection ...

It is a near sphere of protein (cross section ... Structural proteins--N, M and E--move inside the cell, where they help new virions form. A SARS-CoV-2 particle enters a person's nose or mouth ...

HKU5-CoV-2 is found in bats which which was discovered in China and uses the ACE2 receptor for cell entry. It is very similar to SARS-CoV-2 but as per the Wuhan Institute of Virology, HKU5-CoV-2 ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

Shaibani, A. , Maallah, M. and Maallah, A. (2025) Antiviral Activity of Natural Compounds Immuno Formula Shiban2/5 against ...